Skip to content

Comparison of Metacognitive Therapy (MCT) Effectiveness and Cognitive-Behavioral Therapy (CBT) in Patients with Major Depressive Disorder (MDD)

Comparison of Metacognitive Therapy (MCT) Effectiveness and Cognitive-Behavioral Therapy (CBT) in Patients with Major Depressive Disorder (MDD)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201108147328N1
Enrollment
33
Registered
2011-12-24
Start date
2010-05-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depression Disorder. Severe depressive episode without psychotic symptoms

Interventions

Intervention 1: exprimental groups 1- metacognitive therapy 8 session. Intervention 2: control : pharmachotherapy. Intervention 3: Experimental Group 2 Cognitive Behavior Therapy.
Treatment - Other
Treatment - Drugs
Behavior
exprimental groups 1- metacognitive therapy 8 session
control : pharmachotherapy
Experimental Group 2 Cognitive Behavior Therapy

Sponsors

Tehran University of Medical Science, Tehran Psychiatric Institue and Mental Health Research Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: ]Inclusion criteria: Having diagnosis criteria for MDD based on the psychiatrist and psychologist ;diagnoses through diagnostic interview and results of the SCID-I/CV test;Receiving no psychological therapies during six months before participation in the study; Being at least 18 aged to 50; Having at least third level of guidance school; Signing the letter of satisfaction by the patients for participating in the study; Exclusion criteria: Having psychotic symptoms; drug abuse and other psychological disorders placed at Axis I plus having serious suicidal thought as they could not receive and maintain medications; Having complete criteria of personality disorder at Axis II by psychiatrist and psychologist diagnoses through diagnostic interview and results of the SCID-II test.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Depression Severity. Timepoint: pre-test-post-test-follow-up. Method of measurement: BDI-II.;Anxiety. Timepoint: pre-test-post-test-follow-up. Method of measurement: BAI.;Rumination. Timepoint: pre-test-post-test-follow-up. Method of measurement: ruminative response scale (RRS).;Metacognitive Beliefs. Timepoint: pre-test-post-test-follow-up. Method of measurement: Metacognitions Questionnaire-Short Form (MCQ-30),.;Dysfunctional Attitde. Timepoint: pre-test-post-test-follow-up. Method of measurement: Dysfunctional Attitude Scale (DAS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Ashouri

Tehran University of Medical Science, Tehran Psychiatric institute

ahmad.ashouri@gmail.com+98 912 675 4044

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026